Lansoprazole Capsule, Delayed Release
Product Images NDC 55111-398

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 55111-398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Each delayed release capsule contains Lansoprazole USP 1mg and is encased in casted polyethylene. The capsule has the imprint FDYsnd AN and comes with a detailed enclosure for usage instructions. It is advised to keep the package away from children and protected from moisture. The package should be stored at a controlled room temperature of 20°-25°C. It is not tamper-resistant. The product contains 10 capsules (110 unit-dose) and is intended to be dispensed with medication guidance to each patient by a pharmacist.*

FDA Label Image

Carton2 (Carton2)

This is a medication package of Lansoprazole USP 30 mg delayed-release capsules. Each capsule contains the printed text "RDYsnd 39" for product identification. The package contains 10 capsules and should be stored at room temperature between 20-25°C (68-77°F) to protect from moisture. The package is not child-resistant and the prescribing information is enclosed. This medication should be dispensed by a pharmacist with medication guides for each patient.*

FDA Label Image

Container1 (Container1)

FDA Label Image

Container2 (Container2)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.